Home › Funds › KVP Capital Advisors, LP › UTHR

KVP Capital Advisors, LP position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

KVP Capital Advisors, LP reported holding 4,750 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 1.89% of its reported portfolio and ranking #20 among its reported holdings. KVP Capital Advisors, LP has disclosed UTHR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)4.75K sh
Reported value held$2.57M
Portfolio Weight1.89%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How KVP Capital Advisors, LP's UTHR position evolved

KVP Capital Advisors, LP first disclosed a stake in UTHR in Q4 2025 at 4,750 shares (US$2.3M). The position peaked in Q1 2026 at 4,750 shares, worth US$2.8M. Across 3 filings, KVP Capital Advisors, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 4,750 shares valued at US$2.6M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 4.75K $2.31M New
Q1 2026 4.75K $2.82M Hold
Q2 2026 4.75K $2.57M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 43 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$925.8M), ASSETMARK, INC (US$338.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has KVP Capital Advisors, LP held UTHR?

KVP Capital Advisors, LP has disclosed UTHR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is KVP Capital Advisors, LP's current position in UTHR?

As of Q2 2026, KVP Capital Advisors, LP holds 4.75K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $2.57M, representing 1.89% of its reported portfolio and ranking #20.

Has KVP Capital Advisors, LP been buying or selling UTHR?

In the latest 13F filing (Q2 2026), KVP Capital Advisors, LP held unchanged its position in UTHR. The position peaked in Q1 2026 at 4.75K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.